Beijing is soon going to have China's first lab practice and animal testing facility that matches US regulatory standards. This facility, spread over 100,000 square feet, is being developed by Fledgling Bridge Pharmaceutical Inc., a drug research organization. MSNBC reports:
It promises to provide western biopharmaceutical companies the benefits of the lower cost of research in China, while delivering the rigorous data quality needed to pass muster with the U.S. Food and Drug Administration and European regulators.
--
Did you enjoy this post?
The comments to this entry are closed.
« TCS acquires Comicrom, strengthens presence in Chile | Main | Indian IT infrastructure outsourcing firms share market space with global players »
Recent Comments